Stanford University
Showing 30,001-30,050 of 35,019 Results
-
Ryan Taylor, MD
Clinical Assistant Professor, Adult Neurology
BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.
His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.
Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.
He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.
Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology. -
Hamdi Tchelepi
Max Steineke Professor and Senior Fellow at the Precourt Institute for Energy
Current Research and Scholarly InterestsCurrent research activities: (1) model and simulate unstable miscible and immiscible fluid flow in heterogeneous porous media, (2) develop multiscale numerical solution algorithms for coupled mechanics and multiphase fluid flow in large-scale subsurface formations, and (3) develop stochastic solution methods that quantify the uncertainty associated with predictions of fluid-structure dynamics in porous media.
-
Kay Teel
Metadata Librarian for Serials and Arts Resources, Metadata Department
Current Role at StanfordI provide discovery metadata for serial publications in Western European languages in all formats and subject disciplines, and discovery metadata for monographic publications in Western European languages about the arts excluding music.
-
Kamran Tehranchi
Ph.D. Student in Civil and Environmental Engineering, admitted Autumn 2023
BioKamran Tehranchi is a Ph.D. Student in Civil & Environmental Engineering at Stanford University researching planning processes for decarbonized and reliable electricity systems. His work focuses on developing energy system optimization models to support policy analysis. He has previously worked in the public sector as a Shultz Energy Fellow at the California Independent System Operator (CAISO), an analyst at a Community Choice Aggregator (CCA), and within city and county governments. He is a member of the Interdisciplinary Energy Systems research group, advised by Professor Ines Azevedo. He holds a M.S. in Civil & Environmental Engineering from Stanford University and a B.S. in Mechanical Engineering at Northwestern University.
-
David Tehrani, MD, MS
Affiliate,
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Merve Tekgürler
Ph.D. Student in History, admitted Autumn 2019
Masters Student in Symbolic Systems, admitted Autumn 2023BioMerve Tekgürler is a PhD candidate in History (ABD) and an M.S. student in Symbolic Systems. In AY 2023-24, they hold the inaugural Mellon/ACLS Dissertation Innovation Fellowship. Merve has a BA degree in History and Social and Cultural Anthropology from Freie University Berlin and an MA in History from Stanford.
Merve’s dissertation, tentatively titled “Crucible of Empire: Danubian Borderlands and the Making of Ottoman Administrative Mentalities” focuses on the Ottoman-Polish borderlands in the long 18th century (1760s-1820s), examining the changes and continuities north of the Danube River in relation to Russian and Austrian expansions. They study Ottoman news and information networks in this region and their impact on production and mobilisation of imperial knowledge.
As part of their dissertation project, Merve is training a handwritten text recognition model for 18th century Ottoman Turkish administrative hand and developing AI-based natural language processing tools for Ottoman Turkish. Their aim is to compile a large machine-readable corpus of manuscript news communiques and employ computational text analysis methods. In AY 2022-23, they were a Digital Humanities Graduate Fellow at Center for Spatial and Textual Analysis (CESTA) with their project on topic modeling in Ottoman court histories from the 18th and 19th centuries.
Merve’s research on the borderlands ties to their passion for maps and spatial humanities. They are the co-PI in Cistern: A Database of Geographical Knowledge in the Ottoman World, which they started with Adrien Zakar in Winter 2020. They also contributed to their advisor Ali Yaycıoğlu’s Mapping Ottoman Epirus project, building a placenames dataset from an Ottoman transportation map and developing a 3D model of the late-nineteenth century Ottoman Empire with exaggerated elevation data.
Previously, Merve was a G.J. Pigott Scholar (AY 2022-23) and graduate coordinator of Stanford Humanities Center Eurasian Empires Workshop (AY 2021-22 & 2022-23). They also worked as senior graduate mentor for the Undergraduate Research Internship at CESTA from Spring 2021 to Fall 2022. Outside academia, Merve enjoys playing tennis, doing gymnastics, and all kinds of DIY projects. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
